
Aziyo Biologics AZYO
Quarterly report 2026-Q1
added 05-15-2026
Country |
|
IPO year |
2020 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
41.4 M |
Market Cap[1] |
$ 20.5 M |
EBITDA (LTM) |
$ -29.1 M |
P/E (LTM) |
- |
P/S (LTM) |
1.09 |
EPS (LTM) |
-0.59 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 11.37 | 1.52 % | $ 322 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Alphatec Holdings
ATEC
|
$ 8.2 | -0.49 % | $ 1.23 B | Nasdaq Global Select Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 4.37 | 2.88 % | $ 164 M | Nasdaq Global Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Helius Medical Technologies
HSDT
|
$ 2.31 | - | $ 50.9 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.44 | -5.81 % | $ 27.4 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 18.44 | -0.32 % | $ 433 M | Nasdaq Global Select Market,SPB | ||
|
LivaNova PLC
LIVN
|
$ 73.41 | -0.41 % | $ 4 B | Nasdaq Global Select Market | ||
|
Delcath Systems
DCTH
|
$ 11.44 | 1.87 % | $ 410 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
LENSAR
LNSR
|
$ 6.01 | 2.21 % | $ 71.9 M | Nasdaq Capital Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.0 | 0.5 % | $ 16.9 M | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
MiMedx Group
MDXG
|
$ 3.56 | -6.07 % | $ 526 M | Nasdaq Global Select Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.54 | -0.32 % | $ 62.7 M | Nasdaq Global Select Market | ||
|
Electromed
ELMD
|
$ 38.75 | 2.68 % | $ 328 M | NYSE American | ||
|
Myomo
MYO
|
$ 0.92 | 0.14 % | $ 38.5 M | NYSE American | ||
|
Butterfly Network
BFLY
|
$ 4.45 | 1.14 % | $ 1.1 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Sintx Technologies
SINT
|
$ 2.2 | -0.45 % | $ 6.1 M | Nasdaq Capital Market | ||
|
Orthofix Medical
OFIX
|
$ 10.34 | -14.9 % | $ 409 M | Nasdaq Global Select Market,SPB | ||
|
Profound Medical Corp.
PROF
|
$ 6.9 | -0.29 % | $ 209 M | Nasdaq Global Select Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Globus Medical
GMED
|
$ 84.38 | 0.44 % | $ 11.4 B | NYSE,SPB | ||
|
Insulet Corporation
PODD
|
$ 155.0 | -1.02 % | $ 10.9 B | Nasdaq Global Select Market,SPB | ||
|
CONMED Corporation
CNMD
|
$ 36.55 | -1.28 % | $ 1.13 B | NYSE,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 44.17 | 0.07 % | $ 1.3 B | NYSE,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 90.1 | -1.45 % | $ 3.13 B | NYSE,SPB | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Edwards Lifesciences Corporation
EW
|
$ 82.92 | -0.08 % | $ 48.5 B | NYSE,SPB | ||
|
TransMedics Group
TMDX
|
$ 67.66 | -0.5 % | $ 2.3 B | Nasdaq Global Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.